January 5, 2026 · Form 4 insider transaction
Catelani Michael bought 175,000 shares of ANIXA BIOSCIENCES INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.; The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026.